Characterization of Glioblastoma Multiforme (GBM) market

CLIENT

A leading global pharmaceutical company entering into the oncology segment.

OPPORTUNITY

The client was looking for an opportunity to characterize the Glioblastoma Multiforme (GBM) market, thus enabling them to take a business decision on an in-licensing opportunity for an early stage molecule.

SOLUTION

SG Analytics consulted the client in approach selection and performed a critical assessment of the GBM therapeutics market through extensive secondary research. SG Analytics’ experts gathered all relevant information and presented the following insights in a structured report:
  • Disease overview – pathophysiology, etiology and risk factors.
  • Epidemiology – diagnosis, incidence (current and forecasted), prevalence, mortality, and burden of the disease.
  • Disease management – current and evolving treatment regime.
  • Competitive landscape – key players and pipeline analysis.
  • Unmet need analysis.
  • Market forecast.

VALUE DELIVERED

  1. SG Analytics delivered a comprehensive analysis of the GBM therapeutics market and enabled the client to estimate the molecule’s commercial potential.
  1. The report facilitated a well-organized approach towards potential collaboration and helped the client take an informed, data-backed decision.
2
Target geographies covered.
4
Analysts.
4
Weeks delivery period.

VALUE DELIVERED

►
1
SG Analytics delivered a comprehensive analysis of the GBM therapeutics market and enabled the client to estimate the molecule’s commercial potential.
►
2
The report facilitated a well-organized approach towards potential collaboration and helped the client take an informed, data-backed decision.